```html

Zika Conjunctivitis

What is Zika conjunctivitis?

Conjunctivitis, commonly known as “pink eye,” is inflammation of the conjunctiva—the thin, transparent membrane that covers the white part of the eye and lines the inner eyelid. When conjunctivitis occurs as part of a Zika virus infection, it is referred to as Zika conjunctivitis. The Zika virus is an arthropod‑borne flavivirus transmitted primarily by Aedes mosquitoes. In most people the infection is mild, but the virus can involve multiple organ systems, including the eyes. Zika‑related conjunctivitis typically presents as mild to moderate redness, watery discharge, and a gritty sensation, often alongside other systemic Zika symptoms.

Common Causes

While Zika virus infection is a distinct cause, many other infectious and non‑infectious conditions can produce a similar picture of conjunctival inflammation. Understanding the differential diagnosis helps clinicians and patients recognize when an alternate cause may be responsible.

• Zika virus infection – transmitted by infected mosquito bites or sexually.
• Dengue fever – another flavivirus that can cause conjunctival injection.
Other viral infections
• West Nile virus
• Chikungunya
• Enteroviruses (e.g., adenovirus)
• Bacterial conjunctivitis – common pathogens include Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.
• Allergic conjunctivitis – caused by pollen, dust mites, pet dander, or cosmetics.
• Chemical irritation – smoke, chlorine, or industrial fumes.
• Dry‑eye syndrome – Meibomian gland dysfunction or environmental factors.
• Autoimmune conditions – such as Sjögren’s syndrome or rheumatoid arthritis.
• Contact‑lens related irritation – poor hygiene, overwearing, or contaminated lenses.
• Trauma or foreign body – scratches, eyelash “lash” foreign bodies, or splinters.

Associated Symptoms

Conjunctivitis that occurs with Zika infection rarely appears in isolation. Patients often experience a constellation of systemic and neurologic signs that help differentiate it from “simple” pink eye.

• Fever (usually low‑grade)
• Maculopapular rash, beginning on the face and spreading to the trunk
• Arthralgia (joint pain) and myalgia (muscle aches)
• Headache, often described as “constant” or “pressure‑like”
• Mild nausea or anorexia
• Conjunctival hyperemia (redness) with watery or mildly mucopurulent discharge
• Occasional photophobia (light sensitivity)
• In pregnant women, concern for fetal complications (microcephaly, intracranial calcifications)
• Rare neurologic complications such as Guillain‑Barré syndrome or meningoencephalitis

When to See a Doctor

Most cases of Zika‑related conjunctivitis are self‑limited, but certain scenarios require prompt medical evaluation:

• Symptoms persist longer than 7–10 days without improvement.
• Severe eye pain, marked swelling, or vision changes (blurriness, floaters, loss of vision).
• Yellow or thick green discharge suggesting bacterial superinfection.
• High fever (>38.5 °C / 101.3 °F) or systemic signs that worsen.
• Pregnancy – any suspected Zika exposure should trigger immediate prenatal consultation.
• Neurologic signs (tingling, weakness, facial droop, difficulty walking).
• History of recent travel to or residence in an area with active Zika transmission (e.g., parts of Central/South America, Caribbean, Southeast Asia).

Diagnosis

Diagnosis is a stepwise process that combines clinical assessment with targeted laboratory testing.

Clinical Evaluation

1. History taking – travel, mosquito exposure, sexual contact with a potentially infected partner, onset and progression of eye and systemic symptoms.
2. Physical examination – inspection of the conjunctiva, assessment of discharge, measurement of visual acuity, and evaluation for other Zika signs (rash, joint pain).

Laboratory & Imaging Tests

• Polymerase chain reaction (PCR) – Detects Zika RNA in blood, urine, or saliva within the first 1‑2 weeks of infection (CDC).
• Serology (IgM/IgG ELISA) – Useful after the acute phase; cross‑reactivity with other flaviviruses can occur, so confirmatory plaque‑reduction neutralization test (PRNT) may be needed (WHO).
• Complete blood count (CBC) – May show mild leukopenia or thrombocytopenia.
• Ophthalmic imaging (optional) – Slit‑lamp exam can document conjunctival hyperemia, corneal involvement or uveitis; in severe cases, optical coherence tomography (OCT) evaluates retinal changes.
• Pregnancy testing – For women of child‑bearing age, ultrasound and fetal monitoring are recommended if infection is confirmed.

Treatment Options

There is no specific antiviral therapy for Zika virus; treatment focuses on symptom relief, preventing complications, and managing secondary infections.

Medical Management

• Topical lubricants (preservative‑free artificial tears) – Reduce irritation and keep the ocular surface moist.
• Cold compresses – Alleviate swelling and discomfort.
• Oral analgesics/antipyretics – Acetaminophen or ibuprofen for fever, headache, and joint pain (avoid aspirin in children due to Reye’s syndrome).
• Antibiotic eye drops – Reserved for suspected bacterial superinfection (e.g., ciprofloxacin, tobramycin).
• Antihistamine or mast‑cell stabilizer drops – If an allergic component is present.
• Corticosteroid eye drops – Only under ophthalmologist supervision; indicated for severe inflammation or uveitis.

Home Care Measures

• Maintain strict hand hygiene; wash hands frequently with soap and water.
• Avoid touching or rubbing the eyes.
• Use single‑use cotton pads or tissues to wipe discharge; discard immediately.
• Do not share towels, cosmetics, or contact lenses.
• Stay well‑hydrated and get adequate rest to support immune recovery.
• Apply a clean, cold, damp washcloth to the closed eyelids for 10‑15 minutes, 3–4 times a day.

Prevention Tips

Because Zika conjunctivitis is a manifestation of the viral infection, preventing mosquito bites and limiting virus spread are the most effective strategies.

• Vector control
  • Use EPA‑registered insect repellents containing DEET, picaridin, IR3535, or oil of lemon eucalyptus.
  • Wear long‑sleeved shirts, long pants, and socks when outdoors, especially from dawn to dusk.
  • Ensure window and door screens are intact; use air conditioning when possible.
  • Eliminate standing water (flower pots, buckets, old tires) around the home.
• Sexual transmission prevention
  • Condom use for at least 6 weeks after symptom onset (or 8 weeks for men) if a partner could become pregnant.
  • Abstain from sexual activity or use barrier methods if the partner is pregnant.
• Travel precautions
  • Check CDC travel advisories before visiting Zika‑endemic regions.
  • Consider postponing travel for pregnant women or couples planning pregnancy.
• Eye‑specific hygiene
  • Do not share eye makeup or contact lenses.
  • Replace contact lenses and lens solution as recommended; discard lenses after any eye infection.

Emergency Warning Signs

Key Takeaways

Zika conjunctivitis is a mild ocular manifestation of a systemic viral infection that is primarily spread by Aedes mosquitoes. While most cases resolve with supportive care, recognizing associated systemic symptoms, especially in pregnant women, is critical because of the potential for serious fetal outcomes. Prompt evaluation is warranted for persistent eye symptoms, visual changes, or any red‑flag systemic signs. Preventive measures that limit mosquito exposure, practice safe sex, and maintain eye hygiene are the cornerstone of reducing the risk of infection and its ocular sequelae.

References (accessed 2024):

• Mayo Clinic. “Zika virus infection.” mayoclinic.org
• Centers for Disease Control and Prevention. “Zika Virus: Eye Complications.” cdc.gov
• World Health Organization. “Zika virus fact sheet.” who.int
• National Institutes of Health. “Conjunctivitis.” nih.gov
• Cleveland Clinic. “Pink Eye (Conjunctivitis).” my.clevelandclinic.org

```